Structured Medication Review (SMR) DES Requirements

Contractual obligations for Primary Care Networks to deliver structured medication reviews, focusing on clinical priorities outlined in the Network DES Contract.

What are Structured Medication Review (SMR) DES Requirements?

What is ?

The Structured Medication Review (SMR) DES Requirements form part of the Network Contract Directed Enhanced Service (DES), mandating how Primary Care Networks must conduct comprehensive medication reviews for priority patient groups. These requirements specify eligibility criteria, clinical priorities, and delivery standards to optimise medications, reduce inappropriate polypharmacy, and improve patient outcomes. PCNs must employ clinical pharmacists to deliver SMRs according to NICE guidance while meeting specific documentation and reporting obligations.

Structured Medication Review (SMR) DES Requirements Best Practices

What is ?

  • Prioritise patients based on clinical risk factors and identify those who would benefit most from an SMR
  • Ensure clinical pharmacists delivering SMRs have completed the CPPE training or equivalent
  • Implement a structured approach with comprehensive documentation in patient records
  • Establish clear referral pathways within the PCN for complex medication issues
  • Regularly audit SMR activity against contractual requirements and quality markers

Use Structured Medication Review (SMR) DES Requirements in a Sentence

What is ?

  1. The clinical director confirmed that our PCN has met all Structured Medication Review (SMR) DES Requirements for this quarter.
  2. Clinical pharmacists must understand the Structured Medication Review (SMR) DES Requirements before conducting patient reviews.
  3. The updated Structured Medication Review (SMR) DES Requirements now include patients with learning disabilities as a priority group.
Frequently Asked Questions about
Structured Medication Review (SMR) DES Requirements

What does Structured Medication Review (SMR) DES Requirements mean?

Structured Medication Review (SMR) DES Requirements are contractual obligations outlined in the Network Contract Directed Enhanced Service (DES) that specify how Primary Care Networks must deliver comprehensive medication reviews. These requirements define which patient groups should be prioritised, the qualifications needed by clinical pharmacists delivering the service, documentation standards, and outcome metrics that must be reported. The requirements aim to optimise medication use, reduce inappropriate polypharmacy, and improve patient outcomes across the NHS.

Which patient groups are prioritised under the SMR DES Requirements?

Under the SMR DES Requirements, PCNs must prioritise several high-risk patient groups for medication reviews. These include patients taking 10 or more medications (severe polypharmacy), those on high-risk medicines such as lithium or warfarin, residents in care homes, patients with severe frailty or complex needs, those with a learning disability or autism, and patients with complex or problematic pain management requirements. The specific priority groups may be updated annually in the Network Contract DES specification to reflect changing clinical priorities and NHS England guidance.

What qualifications do clinical pharmacists need to deliver SMRs under the DES Requirements?

Clinical pharmacists delivering Structured Medication Reviews under the DES Requirements must have completed the CPPE (Centre for Pharmacy Postgraduate Education) Structured Medication Review training or equivalent. They should also possess advanced consultation and clinical assessment skills, have experience in managing complex polypharmacy, and demonstrate competence in deprescribing when appropriate. Most pharmacists delivering SMRs will be employed through the Additional Roles Reimbursement Scheme (ARRS) and should be working at an advanced practice level equivalent to Band 7/8a in the NHS Agenda for Change pay scale.

How do SMR DES Requirements integrate with other PCN services?

SMR DES Requirements are designed to integrate with other PCN services to provide comprehensive care. They align with the Enhanced Health in Care Homes (EHCH) service, where SMRs are a crucial component of regular clinical reviews for care home residents. They complement the Personalised Care approach by ensuring medication regimes reflect individual patient preferences and goals. SMRs also support other DES requirements such as early cancer diagnosis and cardiovascular disease prevention by identifying medication-related issues that might impact these conditions. Integration with social prescribing and structured approaches to managing long-term conditions ensures a holistic approach to patient care across the PCN.

What are the reporting and monitoring requirements for SMRs under the DES?

PCNs must maintain detailed records of SMR activity to comply with DES Requirements. This includes documenting the number of SMRs completed, patient demographics, reasons for review, outcomes (including medication changes), and follow-up arrangements. Networks must submit quarterly activity data through the Calculating Quality Reporting Service (CQRS) and may be subject to random audits by NHS England. Additionally, PCNs should maintain an internal register of patients requiring an SMR, with clear evidence of prioritisation based on clinical need. From 2022/23, specific quality metrics relating to SMR outcomes have been incorporated into the Investment and Impact Fund (IIF), linking financial incentives to the quality of SMR delivery.

Hire a remote pharmacist
by December 14

Save thousands of hours in pharmacist training, task allocation and prescription processing. Clinical Rx is the all-in-one remote pharmacist solution, ready to go in less than 2 weeks.
Start
 
Prescription Management
Medication Reviews
QOF Management
Discharge Letters
Clinical Supervision
Now
48-72 Hours
12-36 Months
6+ Months
2 Months
2-5 Hrs/Week
3-4 Hours
< 12 Months
1-5 Months
< 1 Week
Included in Contract
{ "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "What does Structured Medication Review (SMR) DES Requirements mean?", "acceptedAnswer": { "@type": "Answer", "text": "Structured Medication Review (SMR) DES Requirements are contractual obligations outlined in the Network Contract Directed Enhanced Service (DES) that specify how Primary Care Networks must deliver comprehensive medication reviews. These requirements define which patient groups should be prioritised, the qualifications needed by clinical pharmacists delivering the service, documentation standards, and outcome metrics that must be reported. The requirements aim to optimise medication use, reduce inappropriate polypharmacy, and improve patient outcomes across the NHS." } }, { "@type": "Question", "name": "Which patient groups are prioritised under the SMR DES Requirements?", "acceptedAnswer": { "@type": "Answer", "text": "Under the SMR DES Requirements, PCNs must prioritise several high-risk patient groups for medication reviews. These include patients taking 10 or more medications (severe polypharmacy), those on high-risk medicines such as lithium or warfarin, residents in care homes, patients with severe frailty or complex needs, those with a learning disability or autism, and patients with complex or problematic pain management requirements. The specific priority groups may be updated annually in the Network Contract DES specification to reflect changing clinical priorities and NHS England guidance." } }, { "@type": "Question", "name": "What qualifications do clinical pharmacists need to deliver SMRs under the DES Requirements?", "acceptedAnswer": { "@type": "Answer", "text": "Clinical pharmacists delivering Structured Medication Reviews under the DES Requirements must have completed the CPPE (Centre for Pharmacy Postgraduate Education) Structured Medication Review training or equivalent. They should also possess advanced consultation and clinical assessment skills, have experience in managing complex polypharmacy, and demonstrate competence in deprescribing when appropriate. Most pharmacists delivering SMRs will be employed through the Additional Roles Reimbursement Scheme (ARRS) and should be working at an advanced practice level equivalent to Band 7/8a in the NHS Agenda for Change pay scale." } }, { "@type": "Question", "name": "How do SMR DES Requirements integrate with other PCN services?", "acceptedAnswer": { "@type": "Answer", "text": "SMR DES Requirements are designed to integrate with other PCN services to provide comprehensive care. They align with the Enhanced Health in Care Homes (EHCH) service, where SMRs are a crucial component of regular clinical reviews for care home residents. They complement the Personalised Care approach by ensuring medication regimes reflect individual patient preferences and goals. SMRs also support other DES requirements such as early cancer diagnosis and cardiovascular disease prevention by identifying medication-related issues that might impact these conditions. Integration with social prescribing and structured approaches to managing long-term conditions ensures a holistic approach to patient care across the PCN." } }, { "@type": "Question", "name": "What are the reporting and monitoring requirements for SMRs under the DES?", "acceptedAnswer": { "@type": "Answer", "text": "PCNs must maintain detailed records of SMR activity to comply with DES Requirements. This includes documenting the number of SMRs completed, patient demographics, reasons for review, outcomes (including medication changes), and follow-up arrangements. Networks must submit quarterly activity data through the Calculating Quality Reporting Service (CQRS) and may be subject to random audits by NHS England. Additionally, PCNs should maintain an internal register of patients requiring an SMR, with clear evidence of prioritisation based on clinical need. From 2022/23, specific quality metrics relating to SMR outcomes have been incorporated into the Investment and Impact Fund (IIF), linking financial incentives to the quality of SMR delivery." } } ] }